Aeterna Zentaris prices offering at $1.20/unit


Aeterna Zentaris (AEZS) raises net proceeds of $12.1M by pricing 11M units at $1.20 each.

Each unit consists of one common share and 0.8 of a warrant to buy one common share at $1.25 each, excercisable for up to five years.

Aeterna Zentaris will use the money to fund its drug development and for general purposes.

Shares are -20.55% at $1.16. (PR)

From other sites
Comments (3)
  • cfriend881
    , contributor
    Comments (601) | Send Message
     
    i was in this stock, just about the time you get a lil profit.....they dilute , and then give all their top echelon a bigger raise...no thanks ...burned too many times..see the reason they say some of the money will be for general purposes......bigger perks and salaries to the brass....
    9 Jan 2014, 11:43 AM Reply Like
  • pchasse
    , contributor
    Comment (1) | Send Message
     
    I am looking into this stock since it has an Orphan rating on Perifosine. However, this message board is worrysome. I did note the multiply dilutions and thought it might be over. Sounds like you expect more stock splits.
    5 Mar 2014, 01:46 AM Reply Like
  • cfriend881
    , contributor
    Comments (601) | Send Message
     
    PCHASSE..last words from me....go back at least three years an look at their history......for your own good.......
    5 Mar 2014, 10:18 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs